From Mechanism to Market

For 20 years Rosa has delivered insights to our clients that would be impossible to obtain in any other way.

PhysioPD Research

PhysioPD® Research is a proprietary approach that translates the physiology, disease pathophysiology, and drug pharmacology of interest into a customized and interactive mathematical Research Platform. PhysioPD delivers credible insights that would be impossible to obtain in any other way. It is used by scientists and clinicians to clarify the connection between disease mechanisms, therapeutic interventions, and clinical outcomes. The result is that decision-makers have a dramatic increase in confidence to develop successful clinical trials and product submissions.

Learn more about PhysioPD Research
PhysioPD Research

ForecastMD Platform

Rosa's ForecastMD™ Platform credibly identifies what product attributes drive physician uptake. Rosa's proprietary methods and technology can explore a breadth of product profiles and competitive scenarios that would be impossible to explore in any other way. The client receives a durable asset that can be used to fine-tune product features and demonstrate the potential commercial demand in a variety of current and future competitive scenarios over multiple years.

Learn more about ForecastMD

Explore our Worldwide Webinar Series

Rosa’s "Impact" webinar series is renowned for its informative discussions on the use of computer modeling and simulation within the global research and development community. Register for an upcoming webinar or download a webinar from the archives.

Explore Webinars

Recent Highlights

Announcing a New DueDiligenceMD Pharma Asset Research Service and AI/ML Capabilities for PhysioPD

Rosa & Co. is pleased to announce it is offering DueDiligenceMD in addition to the ForecastMD™ Research Platform. For organizations that are evaluating assets for in-licensing, partnering, or acquisition, DueDiligenceMD quantifies and explains th... Read More

New Commercial Due Diligence Webinar from Bill Brastow, Ph.D. of Rosa Market Modeling

Rosa & Co. LLC is pleased to announce that Dr. Bill Brastow, Chief Technology Officer for Rosa Market Modeling, will present a webinar "Injecting Reality into Commercial Due Diligence for In-Licensing, Partnering or Purchasing Pharmaceutical Asse... Read More

New video released discussing the important implications of using the ForecastMD™ Platform.

Rosa & Co is pleased to announce the release of a new video discussing how a ForecastMD™ Market Model can quantify physician demand for a prescription drug or diagnostic test under multiple product profiles or competitive scenarios. The video is ... Read More

New video released discussing how the ForecastMD™ Platform is an durable asset for clients

Rosa & Co is pleased to announce the release of a new video discussing how the ForecastMD™ Excel-based Market Model is a durable asset that our clients can use over multiple years to quantify physicians' demand for their prescription drug or diag... Read More

"Rosa is all about doing better science"
—Christina Friedrich, PhD, Chief Engineer, PhysioPD
Learn about PhysioPD Research